J
Jefferson B. Prince
Researcher at Harvard University
Publications - 52
Citations - 3713
Jefferson B. Prince is an academic researcher from Harvard University. The author has contributed to research in topics: Attention deficit hyperactivity disorder & Clinical Global Impression. The author has an hindex of 26, co-authored 52 publications receiving 3577 citations. Previous affiliations of Jefferson B. Prince include North Shore Medical Center & Cambridge Health Alliance.
Papers
More filters
Journal ArticleDOI
A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder
Thomas J. Spencer,Joseph Biederman,Timothy E. Wilens,Robert Doyle,Craig B. H. Surman,Jefferson B. Prince,Eric Mick,Megan Aleardi,Kathleen Herzig,Stephen V. Faraone +9 more
TL;DR: A marked therapeutic response for the MPH treatment of ADHD symptoms that exceeded the placebo response was found and robust doses of MPH are effective in the treatment of adult ADHD.
Journal ArticleDOI
Impact of low birth weight on attention-deficit hyperactivity disorder.
TL;DR: It is found that low birth weight (LBW) is an independent risk factor for ADHD, and children with LBW make up a relatively small proportion of children with ADHD.
Journal ArticleDOI
Efficacy of a Mixed Amphetamine Salts Compound in Adults With Attention-Deficit/ Hyperactivity Disorder
Thomas J. Spencer,Joseph Biederman,Timothy E. Wilens,Stephen V. Faraone,Jefferson B. Prince,Kristine Gerard,Robert Doyle,Asha Parekh,Jake Kagan,Sarah Kate Bearman +9 more
TL;DR: Adderall was effective and well tolerated in the short-term treatment of adults with ADHD and more work is needed to evaluate the long-term effects of Adderall, or other amphetamine compounds, in the treatment of adult attention-deficit/hyperactivity disorder.
Journal ArticleDOI
A Controlled Clinical Trial of Bupropion for Attention Deficit Hyperactivity Disorder in Adults
Timothy E. Wilens,Thomas J. Spencer,Joseph Biederman,Kristine Girard,Robert Doyle,Jefferson B. Prince,David Polisner,Ramon Solhkhah,Sharyn Comeau,Michael C. Monuteaux,Asha Parekh +10 more
TL;DR: The results suggest a therapeutic role for bupropion in the armamentarium of agents for ADHD in adults, while further validating the continuity of pharmacological responsivity of ADHD across the lifespan.
Journal ArticleDOI
A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder.
Timothy E. Wilens,Joseph Biederman,Thomas J. Spencer,Jeff Q. Bostic,Jefferson B. Prince,Michael C. Monuteaux,Jennifer Soriano,Catherine S. Fine,Annah N. Abrams,Michael Rater,David Polisner +10 more
TL;DR: The results of this investigation indicate that ABT-418, a nicotinic analog, may be a potentially useful agent for the treatment of ADHD.